Pulsed arterial spin-labeled MR imaging evaluation of tuberous sclerosis

American Journal of Neuroradiology

Volumn 30, Issue 4, 2009, Pages 815-820

  Pollock, J M ^b   Whitlow, C T ^a   Tan, H ^a   Kraft, R A ^a   Burdette, J H ^a   Maldjian, J A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CHILD; CLINICAL ARTICLE; GRAY MATTER; HAMARTOMA; HUMAN; INFANT; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SPIN LABELING; TUBEROUS SCLEROSIS; TUMOR VOLUME;

ADOLESCENT; ASTROCYTOMA; BRAIN DISEASES; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; EPILEPSY; HAMARTOMA; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDIES; SPIN LABELS; TUBEROUS SCLEROSIS; YOUNG ADULT;

EID: 64649098774     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: 10.3174/ajnr.A1428     Document Type: Article

References (41)

1. Sparagana SP, Roach ES. Tuberous sclerosis complex. Curr Opin Neurol 2000;13:115-19
2. Barkovich AJ, Kuzniecky RI, Jackson GD, et al. A developmental and genetic classification for malformations of cortical development. Neurology 2005;65:1873-87
3. Al-Saleem T, Wessner LL, Scheithauer BW, et al. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 1998;83:2208 -16
4. Padmalatha C, Harruff RC, Ganick D, et al. Glioblastoma multiforme with tuberous sclerosis. Report ofa case. Arch Pathol Lab Med1980;104:649-50
5. Matsumura H, Takimoto H, Shimada N, et al. Glioblastoma following radiotherapy in a patient with tuberous sclerosis. Neurol Med Chir (Tokyo) 1998;38:287-91
6. Mukonoweshuro W, Wilkinson ID, Griffiths PD. Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex. AJNR Am J Neurradiol 2001;22:1920-25
7. Li LM, Cendes F, Bastos AC, et al. Neuronal metabolic dysfunction in patients with cortical developmental malformations: a proton magnetic resonance spectroscopic imaging study. Neurology 1998;50:755-59
8. Matsuo N, Imamura A, Ito R, et al. The correlation between 1H-MR spectroscopy and clinical manifestation with tuberous sclerosis complex. Neuropedi-atrics 2007;38:126-29
9. Yapici Z, Dortcan N, Baykan BB, et al. Neurological aspects of tuberous sclerosis in relation to MRI/MR spectroscopy findings in children with epilepsy. Neurol Res 2007;29:449-54
10. TrombleyIK,MirraSS.Ultrastructureoftuberoussclerosis:corticaltuberand subependymaltumor. Ann Neurol 1981;9:174-81
11. Bender BL, Yunis EJ. The pathology oftuberous sclerosis. Pathol Annu 1982; 17(Pt 1):339-82
12. Mizuguchi M. Abnormal giant cells in the cerebral lesions oftuberous sclerosis complex. Congenit Anom (Kyoto) 2007;47:2-8
13. Chandra PS, Salamon N, Huang J, et al. FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report. Epilepsia 2006;47:1543-49
14. Eluvathingal TJ, Behen ME, Chugani HT, et al. Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates. J Child Neurol 2006;21:846-51
15. Kagawa K, Chugani DC, Asano E, et al. Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-l- tryptophan positron emission tomography (PET). J Child Neurol 2005;20:429-38
16. Widjaja E, Wilkinson ID, Griffiths PD. Magnetic resonance perfusion imaging in malformations of cortical development. Acta Radiol 2007;48:907-17
17. Sieg KG, Harty JR, Simmons M, et al. Tc-99m HMPAO SPECT imaging of the central nervous system in tuberous sclerosis. Clin Nucl Med 1991;16:665-67
18. Koh S, Jayakar P, Resnick T, et al. The localizing value of ictal SPECT in children with tuberous sclerosis complex and refractory partial epilepsy. Epileptic Disord 1999;1:41-46
19. Warmuth C, Nagel S, Hegemann O, etal. Accuracy of blood flow values determined by arterial spin labeling: a validation study in isolated porcine kidneys. J Magn Reson Imaging 2007;26:353-58
20. Detre JA, Zhang W, Roberts DA, et al. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed 1994;7:75-82
21. Luh WM, Wong EC, Bandettini PA, et al. QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999;41:1246-54
22. Maldjian JA, Laurienti PJ, Burdette JH, et al. Clinical implementation of spintag perfusion magnetic resonance imaging. J Comput Assist Tomogr 2008;32:403-06
23. Deibler AR, Pollock JM, Kraft RA, et al. Arterial spin-labeling in routine clin-ical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol 2008;29:1228-34
24. Franz DN. Diagnosis and management of tuberous sclerosis complex. Semin Pediatr Neurol 1998;5:253-68
25. Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80
26. Shepherd CW, Houser OW, Gomez MR. MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. AJNR Am JNeuroradiol 1995;16:149-55
27. Goodman M, Lamm SH, Engel A, et al. Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol 1997;12:85-90
28. Wong V, Khong PL. Tuberous sclerosis complex: correlation of magnetic resonance imaging (MRI) findings with comorbidities. J Child Neurol 2006;21:99-105
29. Nixon JR, Miller GM, Okazaki H, et al. Cerebral tuberous sclerosis: postmortem magnetic resonance imaging and pathologic anatomy. Mayo Clin Proc 1989;64:305-11
30. DiMarioFJJr. Brain abnormalities in tuberous sclerosis complex. J Child Neurol 2004;19:650-57
31. Wang J, Licht DJ. Pediatric perfusion MR imaging using arterial spin labeling. Neuroimaging Clin NAm 2006;16:149-67, ix.
32. Whitlow CT, Pollock JM, Mussat-Whitlow B, et al. Changes in global rates of cerebralperfusionassociatedwithnormaldevelopmentasmeasuredwithMR arterial spin labeling. Annual Meeting of the American Society of Neuroradiology; June 2-5, 2008; New Orleans, La.
33. KohS, JayakarP, DunoyerC, et al. Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia 2000; 41:1206-13
34. Wu JY, Sutherling WW, Koh S, et al. Magnetic source imaging localizes epileptogenic zone in children with tuberous sclerosis complex. Neurology 2006;66:1270-72
35. Karenfort M, Kruse B, Freitag H, et al. Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex. Neuropediatrics 2002;33:255-61
36. Kamimura T, Tohyama J, Oishi M, et al. Magnetoencephalography in patients with tuberous sclerosis and localization-related epilepsy. Epilepsia 2006; 47:991-97
37. Madhavan D, Schaffer S, Yankovsky A, et al. Surgical outcome in tuberous sclerosis complex: a multicenter survey. Epilepsia 2007;48:1625-28
38. Imoto H, Fujii M, Nomura S, et al. [Surgical treatment for intractable epilepsy caused by tuberous sclerosis complex with multiple tubers: case report]. No Shinkei Geka 2008;36:155-58
39. Luat AF, Makki M, Chugani HT. Neuroimagingintuberoussclerosiscomplex. Curr Opin Neurol2007;20: 142-50
40. Jansen FE, Van Huffelen AC, Van Rijen PC, et al. Epilepsy surgery in tuberous sclerosis: the Dutch experience. Seizure 2007;16:445-53
41. Jansen FE, van Huffelen AC, Algra A, et al. Epilepsy surgery in tuberous sclerosis: a systematic review. Epilepsia 2007;48:1477-84